Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yunling Du

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Cardiology|October 2, 2014
Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS StudiesJennifer G Robinson, Helen M Colhoun, Harold E Bays, et al.
Ecotoxicology and Environmental Safety|August 27, 2024
Molecular characterization on the fractionation of organic phosphorus induced by iron oxide adsorption using ESI-FT-ICR MSYongcan Jiang, Minli Guo, Yinlong Shao, et al.
International Journal of Cardiology|April 17, 2007
A brief office intervention is associated with increased days per week of exerciseRobert Jonathan Ostfeld, Yat Wa Cheung, Ilana Saal, et al.
International Journal of Cardiology|October 31, 2006
A brief office intervention is associated with improved health measuresRobert J Ostfeld, Yat Wa Cheung, Ilana Saal, et al.
Frontiers in Microbiology|July 29, 2024
Changes in sediment greenhouse gases production dynamics in an estuarine wetland following invasion by <i>Spartina alterniflora</i>Yongcan Jiang, Yinlong Shao, Jiafang Huang, et al.
Atherosclerosis|December 7, 2015
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trialMichel Farnier, Peter Jones, Randall Severance, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2010
Effects of a school-based intervention for urban adolescents with asthma. A controlled trialJean-Marie Bruzzese, Beverley J Sheares, Elisa J Vincent, et al.
Medical Care|November 24, 2006
Comparison of nurse, system and quality patient care outcomes in 8-hour and 12-hour shiftsPatricia W Stone, Yunling Du, Rhabia Cowell, et al.
Neurosurgery|December 25, 2004
Dobutamine versus milrinone after subarachnoid hemorrhageAndrew Naidech, Yunling Du, Kurt T Kreiter, et al.
Patient Education and Counseling|December 8, 2004
Asthma education: the adolescent experienceJean-Marie Bruzzese, Sebastian Bonner, Elisa J Vincent, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Cardiology|October 2, 2014
Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS StudiesJennifer G Robinson, Helen M Colhoun, Harold E Bays, et al.
Ecotoxicology and Environmental Safety|August 27, 2024
Molecular characterization on the fractionation of organic phosphorus induced by iron oxide adsorption using ESI-FT-ICR MSYongcan Jiang, Minli Guo, Yinlong Shao, et al.
International Journal of Cardiology|April 17, 2007
A brief office intervention is associated with increased days per week of exerciseRobert Jonathan Ostfeld, Yat Wa Cheung, Ilana Saal, et al.
International Journal of Cardiology|October 31, 2006
A brief office intervention is associated with improved health measuresRobert J Ostfeld, Yat Wa Cheung, Ilana Saal, et al.
Frontiers in Microbiology|July 29, 2024
Changes in sediment greenhouse gases production dynamics in an estuarine wetland following invasion by <i>Spartina alterniflora</i>Yongcan Jiang, Yinlong Shao, Jiafang Huang, et al.
Atherosclerosis|December 7, 2015
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trialMichel Farnier, Peter Jones, Randall Severance, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2010
Effects of a school-based intervention for urban adolescents with asthma. A controlled trialJean-Marie Bruzzese, Beverley J Sheares, Elisa J Vincent, et al.
Medical Care|November 24, 2006
Comparison of nurse, system and quality patient care outcomes in 8-hour and 12-hour shiftsPatricia W Stone, Yunling Du, Rhabia Cowell, et al.
Neurosurgery|December 25, 2004
Dobutamine versus milrinone after subarachnoid hemorrhageAndrew Naidech, Yunling Du, Kurt T Kreiter, et al.
Patient Education and Counseling|December 8, 2004
Asthma education: the adolescent experienceJean-Marie Bruzzese, Sebastian Bonner, Elisa J Vincent, et al.
Pageof 3